O‐ GlcNAcylation Mediated by OGA Activates NEK7 / NLRP3 Pathway to Promote Pyroptosis in Parkinson's Disease
Journal of Cellular and Molecular Medicine · 2025-10 · 29 (19)
DOI: 10.1111/jcmm.70874 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 09.10.2025. Verfasst von Zhi Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: NIMA-Related Kinases, Pyroptosis, NLR Family, Pyrin Domain-Containing 3 Protein, Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Fund, Open Fund of Key Laboratory of Hepatosplenic Surgery, Ministry of Education.
Abstract (Originalsprache)
Parkinson's disease (PD) is a neurodegenerative disorder characterised by pyroptosis. O‐GlcNAcylation, regulated solely by O‐GlcNAc transferase (OGT) and O‐GlcNAcase (OGA), has been shown to mitigate PD. This study aimed to investigate whether pyroptosis and PD pathogenesis are modulated by O‐GlcNAcylation. In PD model cells, O‐GlcNAc protein levels were downregulated, while OGA expression was upregulated. Knockdown of OGA significantly protected BV2 cells from LPS‐induced injury by inhibiting pyroptosis. Inhibition of OGA notably increased the O‐GlcNAc levels of NEK7. Furthermore, O‐GlcNAcylated NEK7 protein levels were significantly reduced by mutations at T170 or T172, whereas phosphorylated NEK7 protein levels were downregulated only by mutations at T172. Co‐immunoprecipitation (co‐IP) confirmed the endogenous interaction between NEK7 and NLRP3, which was weakened by OGA knockdown. In animal experiments, OGA deficiency significantly reduced motor dysfunctions and dopaminergic neurodegeneration in MPTP‐treated mice. OGT deficiency abolished the protective effects of OGA knockdown against MPTP‐induced injury. Additionally, OGT inhibition in OGA knockdown mice promoted pyroptosis. Collectively, these findings indicate that high OGA levels decrease O‐GlcNAcylation in PD, thereby promoting pyroptosis via the activation of the NEK7/NLRP3 pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
- Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
ORCID-Profile: Ying Tang
Förderung
- National Natural Science Fund
- Open Fund of Key Laboratory of Hepatosplenic Surgery, Ministry of Education
Zitieren
APA
Wang, Z., Liu, Y., Ma, L., Sun, H., & Tang, Y. (2025). O‐ GlcNAcylation Mediated by OGA Activates NEK7 / NLRP3 Pathway to Promote Pyroptosis in Parkinson's Disease. Journal of Cellular and Molecular Medicine, 29(19). https://doi.org/10.1111/jcmm.70874
Vancouver
Wang Z, Liu Y, Ma L, Sun H, Tang Y. O‐ GlcNAcylation Mediated by OGA Activates NEK7 / NLRP3 Pathway to Promote Pyroptosis in Parkinson's Disease. Journal of Cellular and Molecular Medicine. 2025;29(19). doi:10.1111/jcmm.70874
BibTeX
@article{Wang2025,
author = {Wang, Zhi and Liu, Yue and Ma, Lili and Sun, Hongwei and Tang, Ying},
title = {O‐ GlcNAcylation Mediated by OGA Activates NEK7 / NLRP3 Pathway to Promote Pyroptosis in Parkinson's Disease},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {19},
doi = {10.1111/jcmm.70874}
}
EUVIMED